Loading...
Chemical structure of CAY10626

GC18884

CAY10626

Also known as N-[2-(dimethylamino)ethyl]-N-methyl-4-[[4-[4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)pyrrolo[2,3-d]pyrimidin-2-yl]phenyl]carbamoylamino]benzamide

CAY10626 is a PI3Kα/mTOR dual kinase inhibitor· CAY10626 has IC50s of 0·9, 0·6 nM for PI3Kα and mTOR, respectively· CAY10626 can be used for the research of cancer

ChemicalCAS1202884-94-3MW624.7FormulaC31H35F3N8O3
CAS number
1202884-94-3
Molecular weight
624.7
Formula
C31H35F3N8O3
Solubility
DMF： 15 mg/ml,DMSO： 15 mg/ml,DMSO：PBS (pH 7·2) (1：10)： 0·1 mg/ml
InChIKey
GMASZVAHNYVURN-UHFFFAOYSA-N
Catalogue number
GC18884
Brand
GLPBIO
Computed properties PubChem CID 44599690 · XLogP 3.5 · TPSA 108 Ų · H-bond donors 2
XLogP
3.5
TPSA
108 Ų
H-bond donors
2
H-bond acceptors
10
Rotatable bonds
9
Heavy atoms
45

SMILES CN(C)CCN(C)C(=O)C1=CC=C(C=C1)NC(=O)NC2=CC=C(C=C2)C3=NC4=C(C=CN4CC(F)(F)F)C(=N3)N5CCOCC5

Computed descriptors from PubChem (CID 44599690), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.